Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415479 · ClinicalTrials.gov registry record · NA
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
A NA study of Colonic Neoplasms, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
- 1
- Study location
NCT01415479 is a NA study of Colonic Neoplasms that has completed, run by Indiana University. The registered enrollment target is 212 participants, below the 1,508-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01415479, a NA study of Colonic Neoplasms, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
- 1
- Study location
Study Summary
Fifty thousand people die from colorectal cancer (CRC) every year, making it the second leading cause of death from cancer in the United States. And although there are multiple screening tests that reduce the morbidity and mortality of this disease, less than 60% of eligible individuals are up to date with recommended screening. One of the challenges to improving screening is helping patients understand the range of approved tests, including colonoscopy, sigmoidoscopy, and stool testing (such as fecal immunochemical testing (FIT)). Patients rarely consider all their options, partly due to the limited time they have to learn about them during busy doctor's visits. Computer-based presentations, including decision aids, are a promising tool for improving patient understanding in this and other areas, by giving patients significant amounts of information. But there are important questions about how to design such presentations, including whether they should provide quantitative data about the risks and benefits of screening. Some experts feel that these numbers and graphs are necessary for fully informed decision-making, while others are concerned that they may confuse patients or dissuade them from screening. The investigators have created and pilot tested a computer-based presentation of quantitative information about CRC screening. The investigators found that subjects who viewed the program in a non-healthcare setting exhibited significantly increased interest in screening. In addition, the investigators tested a version of the program that includes a "nudge" towards stool testing with FIT, as a way of encouraging individuals who are confused to undergo some form of screening. In our testing, receiving the nudge was associated with a significant increase in interest in FIT. The investigators now seek to conduct a randomized, controlled study of our computer-based presentation with Clarian patients who are due for CRC screening. All subjects will first view a ge
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Quantitative
- BEHAVIORAL Default
Study Locations (1)
Indiana
- IU Health - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01415479
The ClinicalTrials.gov registry entry for NCT01415479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,508-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (86% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT01415479 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT01415479 about?
NCT01415479 is a clinical study titled "Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening". Fifty thousand people die from colorectal cancer (CRC) every year, making it the second leading cause of death from cancer in the United States. And although there are multiple screening tests that reduce the morbidity and mortality of this disease, less than 60% of eligible individuals are up to da...
What is the current status of trial NCT01415479?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2011-08. Estimated completion is 2013-03.
What conditions does trial NCT01415479 study?
This clinical trial studies the following conditions: Colonic Neoplasms.
What interventions are being tested in trial NCT01415479?
The interventions under investigation include: Control (BEHAVIORAL), Quantitative (BEHAVIORAL), Default (BEHAVIORAL).
Who is sponsoring clinical trial NCT01415479?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01415479 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Strategies for Optimizing a Mailed FIT Program in Appalachia
RECRUITING · NA
-
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
RECRUITING · NA
-
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
RECRUITING · NA
-
Japanese National Computed Tomographic (CT) Colonography Trial
COMPLETED · NA
-
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
COMPLETED · NA
-
Case Series With Saneso 3600 Colonoscope
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.